Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1990-10-24
pubmed:abstractText
In this study, we examined the effect of injecting various cytokines. We report here that tumour necrosis factor (TNF)alpha, gamma-interferon and interleukin 2 (IL-2) can, in some circumstances, increase fetal resorption rates in abortion-prone (CBA/J x DBA/2) and non-abortion prone (CBA/J x BALB/c,C3H x DBA/2) matings: 1000 units TNF enhanced resorptions from 43 to 79% in CBA x DBA/2, from 7 to 89% in CBA x BALB/c, from 5 to 47% in C3H x DBA/2. The effect was both gestational age- and dose-dependent. Gamma interferon and R-IL-2 enhanced resorptions from 38 to 68% and 76% respectively in the CBA/J x DBA/2 mating combination, whereas the rates in CBA/J x BALB/c matings were enhanced from 6 to 44% and 55%. Lipopolysaccharide (LPS), which is known to lead to the release of TNF-alpha, had a similar effect, leading to gestational age- and dose-dependent enhancement of resorptions up to 100%. However, cytokines of the CSF family, including IL-3 and GM-CSF, increased the chances of fetal survival when injected into abortion-prone mice, e.g. reducing resorption rates in the abortion-prone CBA/J x DBA/2 mating combination from 55 to 22% (IL-3), and 47 to 8% (GM-CSF). They also increased fetal and placental weight and, in particular, expanded the spongiotrophoblast zone in the placenta. The latter observations may be due to a direct trophic influence on placental cells, perhaps through a cytokine cascade, or an indirect effect due to inhibition of natural killer (NK)-like cells, or both. Whatever the mechanism, these results may find practical application in influencing reproductive outcome in women and other species.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0022-4251
pubmed:author
pubmed:issnType
Print
pubmed:volume
89
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
447-58
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:2119428-Animals, pubmed-meshheading:2119428-Colony-Stimulating Factors, pubmed-meshheading:2119428-Female, pubmed-meshheading:2119428-Fetal Death, pubmed-meshheading:2119428-Fetal Resorption, pubmed-meshheading:2119428-Fetus, pubmed-meshheading:2119428-Granulocyte-Macrophage Colony-Stimulating Factor, pubmed-meshheading:2119428-Growth Substances, pubmed-meshheading:2119428-Interferon-gamma, pubmed-meshheading:2119428-Interleukin-2, pubmed-meshheading:2119428-Interleukin-3, pubmed-meshheading:2119428-Lymphokines, pubmed-meshheading:2119428-Mice, pubmed-meshheading:2119428-Mice, Inbred BALB C, pubmed-meshheading:2119428-Mice, Inbred C3H, pubmed-meshheading:2119428-Mice, Inbred CBA, pubmed-meshheading:2119428-Mice, Inbred DBA, pubmed-meshheading:2119428-Placenta, pubmed-meshheading:2119428-Pregnancy, pubmed-meshheading:2119428-Tumor Necrosis Factor-alpha
pubmed:year
1990
pubmed:articleTitle
Control of fetal survival in CBA x DBA/2 mice by lymphokine therapy.
pubmed:affiliation
U 262 INSERM, Clinique Universitaire Baudelocque, Paris, France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't